Journey Medical (DERM) EBT Margin (2020 - 2026)
Journey Medical (DERM) reported EBT Margin of 14.01% for Q1 2026, up 1699.0% on a YoY basis from 0.78% in Q1 2025, and down 80.6% quarter-over-quarter from 7.76% in Q4 2025.
Journey Medical (DERM) EBT Margin (2020 - 2026) Analysis & Trends
Journey Medical has reported EBT Margin for 7 years, with the latest figure at 14.01% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 1699.0% year-over-year to 14.01%; the trailing twelve-month figure through Mar 2026 stood at 14.88% (down 23.0% YoY), and the FY2025 full-year result was 18.38%, up 765.0% from the prior year.
- EBT Margin for Q1 2026 stood at 14.01%, down from 7.76% in the prior quarter.
- The five-year high for EBT Margin was 110.5% in Q3 2023, with the low at 82.99% in Q1 2023.
- Historically, EBT Margin has averaged 20.01% across 5 years, with a median of 22.63% in 2024.
- Annual changes were most pronounced in 2023 — EBT Margin surged 17327 bps — and 2024, when it sank 12684 bps.
- Journey Medical's EBT Margin stood at 57.16% in 2022, then soared by 183 bps to 47.33% in 2023, then slumped by 75 bps to 11.62% in 2024, then slumped by 167 bps to 7.76% in 2025, then tumbled by 81 bps to 14.01% in 2026.
- The last three EBT Margin figures came in at 14.01% (Q1 2026), 7.76% (Q4 2025), and 13.6% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -156.77% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.70% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 41.45% |
| 10 | Journey Medical | 168.75 Mn | 141.53 Mn | 9.70 Mn | -14.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.01% |
| Dec 31, 2025 | -7.76% |
| Sep 30, 2025 | -13.60% |
| Jun 30, 2025 | -24.89% |
| Mar 31, 2025 | -31.00% |
| Dec 31, 2024 | 11.62% |
| Sep 30, 2024 | -16.34% |
| Jun 30, 2024 | -22.63% |
| Mar 31, 2024 | -80.14% |
| Dec 31, 2023 | 47.33% |
| Sep 30, 2023 | 110.50% |
| Jun 30, 2023 | -48.70% |
| Mar 31, 2023 | -82.99% |
| Dec 31, 2022 | -57.16% |
| Sep 30, 2022 | -62.77% |
| Jun 30, 2022 | -41.51% |
| Mar 31, 2022 | -6.13% |
| Dec 31, 2021 | -76.59% |
| Sep 30, 2021 | -71.50% |
| Jun 30, 2021 | -99.99% |